{"cdcTestId":"2021-0011","testcaseName":"Dose #1 and dose #2 of the Novavax Covid-19 vaccine.","vaccineGroup":"COVID-19","evaluationTestType":"All Valid: Forecast Test Type","forecastTestType":"Recommended based on interval","assessmentDate":"2022-10-19T00:00:00","patient":{"dob":"1988-09-28T00:00:00","gender":"M"},"evaluation":{"seriesStatus":"Not complete","administeredDoses":[{"dateAdministered":"2022-09-28T00:00:00","vaccineName":"Novavax COVID-19 Vaccine","cvx":"211","mvx":"NVX","evaluationStatus":"Valid","evaluationReason":null},{"dateAdministered":"2022-10-19T00:00:00","vaccineName":"Novavax COVID-19 Vaccine","cvx":"211","mvx":"NVX","evaluationStatus":"Valid","evaluationReason":null}]},"forecast":{"forecastNum":"3","earliestDate":"2022-12-14T00:00:00","recommendedDate":"2022-12-14T00:00:00","pastDueDate":"0001-01-01T00:00:00"},"doses":[{"dateAdministered":"2022-09-28T00:00:00","vaccineName":"Novavax COVID-19 Vaccine","cvx":"211","mvx":"NVX","evaluationStatus":"Valid","evaluationReason":null},{"dateAdministered":"2022-10-19T00:00:00","vaccineName":"Novavax COVID-19 Vaccine","cvx":"211","mvx":"NVX","evaluationStatus":"Valid","evaluationReason":null}],"dateAdded":"2021-08-22T20:00:00","dateUpdated":"2022-09-20T06:41:13.393","generalDescription":"This test case describes when an adult is administered the Novavax Covid-19 vaccine as the first and second dose (21 day interval) that the doses are considered valid. Another dose should be forecast.","changedInVersion":"4.27","reasonForChange":"v4.27 Added forecast for a bivalent booster\nv4.25  Updated test cast to align with the current Interim Clinical Considerations on 07/20/2022 concerning the use of the Novavax Covid-19 vaccine and that two doses with an interval of 21 days is currently considered a completed series.\nv4.20 Updated test case to align with Interim Clinical Considerations for \u0022People who received Covid-19 vaccine outside of the United States\u0022 by forecasting a third dose."}